B. Metzler seel. Sohn & Co’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $142M | Buy |
319,621
+5,278
| +2% | +$2.35M | 1.36% | 18 |
|
|
2025
Q1 | $152M | Buy |
314,343
+233,584
| +289% | +$113M | 1.57% | 18 |
|
|
2024
Q4 | $32.4M | Buy |
80,759
+40,766
| +102% | +$16.3M | 0.33% | 55 |
|
|
2024
Q3 | $18.6M | Buy |
39,993
+4,758
| +14% | +$2.21M | 0.18% | 75 |
|
|
2024
Q2 | $16.5M | Buy |
35,235
+19,699
| +127% | +$9.23M | 0.16% | 75 |
|
|
2024
Q1 | $6.5M | Sell |
15,536
-64
| -0.4% | -$26.8K | 0.07% | 141 |
|
|
2023
Q4 | $6.35M | Sell |
15,600
-586
| -4% | -$238K | 0.08% | 144 |
|
|
2023
Q3 | $5.63M | Buy |
16,186
+586
| +4% | +$204K | 0.08% | 142 |
|
|
2023
Q2 | $5.49M | Sell |
15,600
-2,373
| -13% | -$835K | 0.07% | 185 |
|
|
2023
Q1 | $5.66M | Sell |
17,973
-2,326
| -11% | -$733K | 0.09% | 138 |
|
|
2022
Q4 | $5.86M | Sell |
20,299
-3,695
| -15% | -$1.07M | 0.1% | 139 |
|
|
2022
Q3 | $6.95M | Buy |
23,994
+756
| +3% | +$219K | 0.13% | 118 |
|
|
2022
Q2 | $6.55M | Sell |
23,238
-148
| -0.6% | -$41.7K | 0.11% | 136 |
|
|
2022
Q1 | $6.1M | Buy |
23,386
+71
| +0.3% | +$18.5K | 0.08% | 159 |
|
|
2021
Q4 | $5.19M | Buy |
23,315
+3,852
| +20% | +$857K | 0.07% | 182 |
|
|
2021
Q3 | $3.53M | Buy |
19,463
+1,000
| +5% | +$181K | 0.05% | 220 |
|
|
2021
Q2 | $3.72M | Buy |
18,463
+517
| +3% | +$104K | 0.06% | 194 |
|
|
2021
Q1 | $3.86M | Buy |
17,946
+1,157
| +7% | +$249K | 0.06% | 189 |
|
|
2020
Q4 | $3.92M | Buy |
+16,789
| New | +$3.92M | 0.07% | 164 |
|